{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:32:12Z","timestamp":1777577532034,"version":"3.51.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["VIR\/12\/2022\/ECD-1"],"award-info":[{"award-number":["VIR\/12\/2022\/ECD-1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008758","name":"Council of Science and Technology, U.P.","doi-asserted-by":"publisher","award":["UP-CST\/D-2245"],"award-info":[{"award-number":["UP-CST\/D-2245"]}],"id":[{"id":"10.13039\/501100008758","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cyto.2023.156435","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T19:10:47Z","timestamp":1699557047000},"page":"156435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Leishmania antigens activated CD4+ T cells expressing CD200R receptors are the prime IL-10 producing phenotype and an important determinant of visceral leishmaniasis pathogenesis"],"prefix":"10.1016","volume":"173","author":[{"given":"Abhishek","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baishakhi","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpita","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangram","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikash K.","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2023.156435_b0005","first-page":"9872095","article-title":"Current visceral leishmaniasis research: a research review to inspire future study","author":"Bi","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"460","key":"10.1016\/j.cyto.2023.156435_b0010","first-page":"1","article-title":"vectors, A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries","volume":"9","author":"Al-Salem","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.cyto.2023.156435_b0015","series-title":"Regional Office for South-East, Report of Meeting of the Regional Technical Advisory Group (RTAG) on visceral leishmaniasis and the national visceral leishmaniasis programme managers of endemic member states","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.cyto.2023.156435_b0020","first-page":"66","volume":"25","year":"2019","journal-title":"Leishmaniasis among neighbouring endemic countries in the the Easrtern Mediterranean, African and European regions. East. Mediterr. Health J."},{"issue":"12","key":"10.1016\/j.cyto.2023.156435_b0025","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"Alvar","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.cyto.2023.156435_b0030","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.ijantimicag.2010.06.023","article-title":"Leishmaniasis in the world health organization eastern mediterranean region","volume":"36","author":"Postigo","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/1995-7645.225016","article-title":"Visceral leishmaniasis: an immunological viewpoint on asymptomatic infections and post kala azar dermal leishmaniasis","volume":"11","author":"Tiwari","year":"2018","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"11","key":"10.1016\/j.cyto.2023.156435_b0040","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/14787210.2018.1532790","article-title":"Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence","volume":"16","author":"Sundar","year":"2018","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.cyto.2023.156435_b0045","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211036787","article-title":"Clinical and laboratory profiles of visceral leishmaniasis among adult patients admitted to Felege Hiwot Hospital, Bahir Dar, Ethiopia","volume":"9","author":"Tarekegn","year":"2021","journal-title":"SAGE Open Med."},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pt.2013.12.004","article-title":"Post kala-azar dermal leishmaniasis: an unresolved mystery","volume":"30","author":"Mukhopadhyay","year":"2014","journal-title":"Trends Parasitol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156435_b0055","doi-asserted-by":"crossref","first-page":"e0285663","DOI":"10.1371\/journal.pone.0285663","article-title":"The stigma associated with cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL): a protocol for a systematic review","volume":"18","author":"Nuwangi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2023.156435_b0060","first-page":"98","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3","author":"Sundar","year":"2016","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.cyto.2023.156435_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40249-016-0112-2","article-title":"Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective","volume":"5","author":"Singh","year":"2016","journal-title":"Infect. Dis. Poverty."},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0974-777X.62883","article-title":"Treatment of visceral leishmaniasis","volume":"2","author":"Moore","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"issue":"7","key":"10.1016\/j.cyto.2023.156435_b0075","doi-asserted-by":"crossref","first-page":"e0008221","DOI":"10.1371\/journal.pntd.0008221","article-title":"Post kala-azar dermal leishmaniasis: A threat to elimination program","volume":"14","author":"Gedda","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.cyto.2023.156435_b0080","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin. Transl. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis vaccine: where are we today?","volume":"2","author":"Kedzierski","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"issue":"9","key":"10.1016\/j.cyto.2023.156435_b0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nyl\u00e9n","year":"2007","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156435_b0095","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1365-2249.1999.00918.x","article-title":"Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis","volume":"116","author":"Kemp","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156435_b0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2023.156435_b0105","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jir461","article-title":"IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis","volume":"204","author":"Gautam","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cyto.2023.156435_b0110","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/152741","article-title":"Potential use of interleukin-10 blockade as a therapeutic strategy in human cutaneous leishmaniasis","volume":"2015","author":"Castellano","year":"2015","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.cyto.2023.156435_b0115","doi-asserted-by":"crossref","first-page":"e1003476","DOI":"10.1371\/journal.ppat.1003476","article-title":"T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine","volume":"9","author":"Schwarz","year":"2013","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.cyto.2023.156435_b0120","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.194.10.1497","article-title":"The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti\u2013IL-10 receptor antibody for sterile cure","volume":"194","author":"Belkaid","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2023.156435_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.835711","article-title":"T lymphocyte exhaustion during human and experimental visceral leishmaniasis","volume":"13","author":"Costa-Madeira","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156435_b0130","doi-asserted-by":"crossref","first-page":"e20190418","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2019","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0135","doi-asserted-by":"crossref","first-page":"e0004422","DOI":"10.1371\/journal.pntd.0004422","article-title":"Induction of IL-10 and TGF\u03b2 from CD4+CD25+FoxP3+ T cells correlates with parasite load in indian kala-azar patients infected with leishmania donovani","volume":"10","author":"Bhattacharya","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20061886","article-title":"Sacks CD4+CD25\u2212Foxp3\u2212 Th1 cells are the source of IL-10\u2013mediated immune suppression in chronic cutaneous leishmaniasis","volume":"204","author":"Anderson","year":"2007","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.cyto.2023.156435_b0145","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/502980","article-title":"Barral, CD4+ CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells","volume":"193","author":"Campanelli","year":"2006","journal-title":"J Infect Dis"},{"issue":"6915","key":"10.1016\/j.cyto.2023.156435_b0150","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4+ CD25+ regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Belkaid","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cyto.2023.156435_b0155","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"Nyl\u00e9n","year":"2007","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.imbio.2008.07.001","article-title":"Identification of regulatory T cells during experimental Leishmania infantum infection","volume":"214","author":"Rodrigues","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.cyto.2023.156435_b0165","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fimmu.2019.00360","article-title":"Cross-talk between antigen presenting cells and t cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis","volume":"10","author":"Gaudino","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2023.156435_b0170","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.3389\/fimmu.2017.01880","article-title":"Nivolumab enhances in vitro effector functions of PD-1+ T-lymphocytes and leishmania-infected human myeloid cells in a host cell-dependent manner","volume":"8","author":"Filippis","year":"2017","journal-title":"Front Immuol."},{"issue":"6","key":"10.1016\/j.cyto.2023.156435_b0175","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/314520","article-title":"Unresponsive CD4+ T Lymphocytes from Leishmania chagasi\u2014Infected Mice Increase Cytokine Production and Mediate Parasite Killing after Blockade of B7\u20131\/CTLA-4 Molecular Pathway","volume":"178","author":"Gomes","year":"1998","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.cyto.2023.156435_b0180","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.4049\/jimmunol.171.6.3034","article-title":"Characterization of the CD200 receptor family in mice and humans and their interactions with CD200","volume":"171","author":"Wright","year":"2003","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156435_b0185","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.molimm.2007.07.013","article-title":"The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes","volume":"45","author":"Rijkers","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cyto.2023.156435_b0190","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/682168","article-title":"CD200:CD200R-mediated regulation of immunity","author":"Gorczynski","year":"2012","journal-title":"ISRN Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2023.156435_b0195","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.4049\/jimmunol.0901531","article-title":"Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid Cells1","volume":"183","author":"Mihrshahi","year":"2009","journal-title":"J. Immunol."},{"issue":"5497","key":"10.1016\/j.cyto.2023.156435_b0200","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1126\/science.290.5497.1768","article-title":"Down-regulation of the macrophage lineage through interaction with OX2 (CD200)","volume":"290","author":"Hoek","year":"2000","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cyto.2023.156435_b0205","first-page":"488","article-title":"Augmented induction of CD4+ CD25+ Treg using monoclonal antibodies to CD200R","volume":"79","author":"Gorczynski","year":"2005","journal-title":"Transplantation"},{"issue":"24","key":"10.1016\/j.cyto.2023.156435_b0210","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1038\/onc.2011.477","article-title":"RA van Schaarenburg, CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor","volume":"31","author":"Rygiel","year":"2012","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cyto.2023.156435_b0215","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.leukres.2008.08.021","article-title":"Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade","volume":"33","author":"Pallasch","year":"2009","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.cyto.2023.156435_b0220","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1073\/pnas.0510081103","article-title":"Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation","volume":"103","author":"McWhirter","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.cyto.2023.156435_b0225","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00262-007-0429-6","article-title":"Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200","volume":"57","author":"Siva","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.cyto.2023.156435_b0230","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.4049\/jimmunol.0900252","article-title":"Lack of CD200 enhances pathological T cell responses during influenza infection","volume":"183","author":"Rygiel","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156435_b0235","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.chom.2010.08.005","article-title":"Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia","volume":"8","author":"Mukhopadhyay","year":"2010","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.cyto.2023.156435_b0240","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1128\/JVI.07168-11","article-title":"Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue","volume":"86","author":"Misstear","year":"2012","journal-title":"J. Virol. CD200"},{"issue":"9","key":"10.1016\/j.cyto.2023.156435_b0245","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ni.1637","article-title":"A critical function for CD200 in lung immune homeostasis and the severity of influenza infection","volume":"9","author":"Snelgrove","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2023.156435_b0250","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijbiomac.2020.02.189","article-title":"The CD200-CD200R cross-talk helps Leishmania donovani to down regulate macrophage and CD4(+)CD44(+) T cells effector functions in an NF\u03baB independent manner","volume":"151","author":"Rawat","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cyto.2023.156435_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.793611","article-title":"CD300a receptor blocking enhances early clearance of Leishmania donovani from its mammalian host through modulation of effector functions of phagocytic and antigen experienced T cells","volume":"12","author":"Singh","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2023.156435_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2023.106826","article-title":"Leishmania donovani induces CD300a expression to dampen effector properties of CD11c(+) dendritic and antigen activated CD8(+) T cells","volume":"239","author":"Anand","year":"2023","journal-title":"Acta Trop."},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/expr.2001.4656","article-title":"A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation","volume":"99","author":"Spath","year":"2001","journal-title":"Exp. Parasitol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156435_b0270","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2023.156435_b0275","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production","volume":"141","author":"Ding","year":"1988","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2023.156435_b0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.cyto.2023.156435_b0285","first-page":"412","article-title":"Immunobiology of leishmaniasis","volume":"47","author":"Sharma","year":"2009","journal-title":"Indian J. Exp. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156435_b0290","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4049\/jimmunol.1203518","article-title":"Leishmania-infected MHC class IIhigh dendritic cells polarize CD4+ T cells toward a nonprotective T-bet+ IFN-\u03b3+ IL-10+ phenotype","volume":"191","author":"Resende","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156435_b0295","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1600-065X.2010.00983.x","article-title":"Cell biology and immunology of Leishmania","volume":"240","author":"Mougneau","year":"2011","journal-title":"Immunol. Rev."},{"issue":"45","key":"10.1016\/j.cyto.2023.156435_b0300","doi-asserted-by":"crossref","first-page":"27158","DOI":"10.1074\/jbc.M115.682708","article-title":"Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS","volume":"290","author":"Mittal","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2023.156435_b0305","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3389\/fimmu.2018.01176","article-title":"Centrin-deleted leishmania donovani parasites Help CD4+ T Cells to Acquire Th1 phenotype and multi-functionality through downregulation of CD200\u2013CD200R immune inhibitory axis","volume":"9","author":"Singh","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2023.156435_b0310","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.4049\/jimmunol.174.11.7147","article-title":"CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection","volume":"174","author":"Ji","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0315","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.smim.2003.12.005","article-title":"Human CD4+CD25+ regulatory T cells","volume":"16","author":"Baecher-Allan","year":"2004","journal-title":"Semin. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156435_b0320","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.4049\/jimmunol.166.5.3008","article-title":"CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-101","volume":"166","author":"Annacker","year":"2001","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156435_b0325","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/eji.201646875","article-title":"Immune checkpoints and their inhibition in cancer and infectious diseases","volume":"47","author":"Dyck","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156435_b0330","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006908","article-title":"Historical overview of immunological tolerance","volume":"4","author":"Schwartz","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cyto.2023.156435_b0335","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fimmu.2015.00310","article-title":"Inhibitory Receptors Beyond T Cell Exhaustion","volume":"6","author":"Fuertes Marraco","year":"2015","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0340","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2567.2001.01163.x","article-title":"The unusual distribution of the neuronal\/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans","volume":"102","author":"Wright","year":"2001","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.cyto.2023.156435_b0345","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/ijms22041602","article-title":"CD200:CD200R interactions and their importance in immunoregulation","volume":"22","author":"Kotwica-Mojzych","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cyto.2023.156435_b0350","doi-asserted-by":"crossref","first-page":"1002710","DOI":"10.1371\/journal.ppat.1002710","article-title":"CD200 receptor controls sex-specific TLR7 responses to viral infection","volume":"8","author":"Karnam","year":"2012","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.cyto.2023.156435_b0355","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41467-019-10156-6","article-title":"CD200R deletion promotes a neutrophil niche for Francisella tularensis and increases infectious burden and mortality","volume":"10","author":"Casulli","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2023.156435_b0360","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-030-35582-1_8","article-title":"CD200-CD200R pathway in the regulation of tumor immune microenvironment and immunotherapy","volume":"1223","author":"Liu","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"10","key":"10.1016\/j.cyto.2023.156435_b0365","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1128\/IAI.73.10.6372-6382.2005","article-title":"Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis","volume":"73","author":"Breton","year":"2005","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.cyto.2023.156435_b0370","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.188.8.1547","article-title":"Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity","volume":"188","author":"von Stebut","year":"1998","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0375","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<687::AID-IMMU687>3.0.CO;2-N","article-title":"Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection","volume":"28","author":"Gorak","year":"1998","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156435_b0380","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1189\/jlb.1009659","article-title":"A role for STAT3 and cathepsin S in IL-10 down-regulation of IFN-\u03b3-induced MHC class II molecule on primary human blood macrophages","volume":"88","author":"Chan","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"12","key":"10.1016\/j.cyto.2023.156435_b0385","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ni861","article-title":"Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis","volume":"3","author":"Ato","year":"2002","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156435_b0390","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.exppara.2010.02.010","article-title":"Role of chemokines in regulation of immunity against leishmaniasis","volume":"126","author":"Oghumu","year":"2010","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cyto.2023.156435_b0395","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2023.156435_b0400","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.4049\/jimmunol.154.10.5320","article-title":"IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis","volume":"154","author":"Scharton-Kersten","year":"1995","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2023.156435_b0405","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.185.7.1231","article-title":"Intracellular antimicrobial activity in the absence of interferon-\u03b3: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-\u03b3 gene-disrupted mice","volume":"185","author":"Taylor","year":"1997","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.cyto.2023.156435_b0410","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.4049\/jimmunol.150.9.3924","article-title":"IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts","volume":"150","author":"Heinzel","year":"1993","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2023.156435_b0415","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K","article-title":"Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages","volume":"28","author":"Huang","year":"1998","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156435_b0420","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1172\/JCI72058","article-title":"Collective nitric oxide production provides tissue-wide immunity during Leishmania infection","volume":"124","author":"Olekhnovitch","year":"2014","journal-title":"J. Clin. Invest."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623003137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623003137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T10:10:10Z","timestamp":1736417410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623003137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":84,"alternative-id":["S1043466623003137"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156435","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leishmania antigens activated CD4+ T cells expressing CD200R receptors are the prime IL-10 producing phenotype and an important determinant of visceral leishmaniasis pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156435"}}